NCT02912468: A reported trial by Sanofi
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02912468 |
|---|---|
| Title | A Randomized, 24-Week Treatment, Double-blind, Placebo-controlled Efficacy and Safety Study of Dupilumab 300 mg Every Other Week, in Patients With Bilateral Nasal Polyposis on a Background Therapy With Intranasal Corticosteroids |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Dec. 5, 2016 |
| Completion date | July 5, 2018 |
| Required reporting date | July 5, 2019, midnight |
| Actual reporting date | July 3, 2019 |
| Date last checked at ClinicalTrials.gov | Dec. 15, 2025 |
| Days late | None |